1
|
Liu R, Wang Y, Xiao Y, Shi M, Zhang G and
Guo B: SnoN as a key regulator of the high glucose-induced
epithelial-mesenchymal transition in cells of the proximal tubule.
Kidney Blood Press Res. 35:517–528. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wang YY, Liu RX, Guo B, Xiao Y, Shi MJ, Pi
MJ, Wen QY and Zhang GZ: Down-regulation of PTEN expression in
kidney and its role in development of diabetic nephropathy in rats.
Sheng Li Xue Bao. 63:325–332. 2011.(In Chinese). PubMed/NCBI
|
3
|
Wang Z, Zhao J, Zhang J, Wei J, Zhang J
and Huang Y: Protective effect of BMP-7 against aristolochic
acid-induced renal tubular epithelial cell injury. Toxicol Lett.
198:348–357. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Luo DD, Phillips A and Fraser D: Bone
morphogenetic protein-7 inhibits proximal tubular epithelial cell
Smad3 signaling via increased SnoN expression. Am J Pathol.
176:1139–1147. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Wang S, de Caestecker M, Kopp J, Mitu G,
Lapage J and Hirschberg R: Renal bone morphogenetic protein-7
protects against diabetic nephropathy. J Am Soc Nephrol.
17:2504–2512. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
López-Hernández FJ and López-Novoa JM:
Role of TGF-β in chronic kidney disease: An integration of tubular,
glomerular and vascular effects. Cell Tissue Res. 347:141–154.
2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Deheuninck J and Luo K: Ski and SnoN,
potent negative regulators of TGF-beta signaling. Cell Res.
19:47–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Liu S, Yu N, Zhang XL, Chen XQ and Tang
LQ: Regulatory effect of berberine on unbalanced expressions of
renal tissue TGF-beta1/SnoN and smad signaling pathway in rats with
early diabetic nephropathy. Zhongguo Zhong Yao Za Zhi.
37:3604–3610. 2012.(In Chinese). PubMed/NCBI
|
9
|
Xu YF, Wan JX and Jiang DW: Effects of
bone morphogenic protein-7 on transdifferentiation and the
expression of connective tissue growth factor of human renal
tubular epithelial cells induced by transforming growth
factor-beta1. Zhonghua Yi Xue Za Zhi. 89:1639–1644. 2009.(In
Chinese). PubMed/NCBI
|
10
|
Xu Y, Wan J, Jiang D and Wu X: BMP-7
counteracts TGF-beta1-induced epithelial-to-mesenchymal transition
in human renal proximal tubular epithelial cells. J Nephrol.
22:403–410. 2009.PubMed/NCBI
|
11
|
Jahchan NS and Luo K: SnoN in mammalian
development, function and diseases. Curr Opin Pharmacol.
10:670–675. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Tan R, Zhang J, Tan X, Zhang X, Yang J and
Liu Y: Downregulation of SnoN expression in obstructive nephropathy
is mediated by an enhanced ubiquitin-dependent degradation. J Am
Soc Nephrol. 17:2781–2791. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhu Q, Pearson-White S and Luo K:
Requirement for the SnoN oncoprotein in transforming growth factor
beta-induced oncogenic transformation of fibroblast cells. Mol Cell
Biol. 25:10731–10744. 2005. View Article : Google Scholar : PubMed/NCBI
|
14
|
Nanjundan M, Cheng KW, Zhang F, Lahad J,
Kuo WL, Schmandt R, Smith-McCune K, Fishman D, Gray JW and Mills
GB: Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in
ovarian cancers: A role in ovarian pathogenesis. Mol Oncol.
2:164–181. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Fukasawa H, Yamamoto T, Togawa A, Ohashi
N, Fujigaki Y, Oda T, Uchida C, Kitagawa K, Hattori T, Suzuki S, et
al: Ubiquitin-dependent degradation of SnoN and Ski is increased in
renal fibrosis induced by obstructive injury. Kidney Int.
69:1733–1740. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Miyazono K and Koinuma D: Arkadia-beyond
the TGF-β pathway. J Biochem. 149:1–3. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Sakairi T, Hiromura K, Takahashi S,
Hamatani H, Takeuchi S, Tomioka M, Maeshima A, Kuroiwa T and Nojima
Y: Effects of proteasome inhibitors on rat renal fibrosis in vitro
and in vivo. Nephrology (Carlton). 16:76–86. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Bonni S, Wang HR, Causing CG, Kavsak P,
Stroschein SL, Luo K and Wrana JL: TGF-beta induces assembly of a
Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for
degradation. Nat Cell Biol. 3:587–595. 2001. View Article : Google Scholar : PubMed/NCBI
|
19
|
Nagano Y, Mavrakis KJ, Lee KL, Fujii T,
Koinuma D, Sase H, Yuki K, Isogaya K, Saitoh M, Imamura T, et al:
Arkadia induces degradation of SnoN and c-Ski to enhance
transforming growth factor-beta signaling. J Biol Chem.
282:20492–20501. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yang G, Zhu Z, Wang Y, Gao A, Niu P and
Tian L: Bone morphogenetic protein-7 inhibits silica-induced
pulmonary fibrosis in rats. Toxicol Lett. 220:103–108. 2013.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang SL, Yang CQ, Qi XL, Yuan M, Chang YZ,
Yang L and Gao HJ: Inhibitory effect of bone morphogenetic
protein-7 on hepatic fibrosis in rats. Int J Clin Exp Pathol.
6:897–903. 2013.PubMed/NCBI
|
22
|
Zeisberg M, Bottiglio C, Kumar N, Maeshima
Y, Strutz F, Muller GA and Kalluri R: Bone morphogenic protein-7
inhibits progression of chronic renal fibrosis associated with two
genetic mouse models. Am J Physiol Renal Physiol. 285:F1060–F1067.
2003. View Article : Google Scholar : PubMed/NCBI
|
23
|
Yang SW, Wang W, Xu ZC and Zhu YY:
Construction of recombinant adenovirus containing BMP-7 gene and
its expression in proximal tubule epithelial cells. Zhejiang Da Xue
Xue Bao Yi Xue Ban. 39:71–78. 2010.(In Chinese). PubMed/NCBI
|
24
|
Wang SN, Lapage J and Hirschberg R: Loss
of tubular bone morphogenetic protein-7 in diabetic nephropathy. J
Am Soc Nephrol. 12:2392–2399. 2001.PubMed/NCBI
|